Articles from Integrated DNA Technologies

Global genomics solutions leader Integrated DNA Technologies (IDT) and Elegen, the leader in next-generation DNA manufacturing, are teaming up to offer IDT customers early access to Elegen’s ENFINIA™ Plasmid DNA, a long and high-complexity clonal gene synthesis service. Through this partnership, IDT early access customers will, for the first time, have access to a cost-effective solution for NGS-verified 5 kb to 15 kb clonal genes, shipped from Elegen’s U.S. facility, in as fast as 10 business days.

Global genomics solutions leader Integrated DNA Technologies (IDT) has appointed Ajay Gannerkote as president, effective immediately. With a track record of driving growth and transformation across myriad sectors—including pharmaceuticals, medical devices, imaging, and healthcare providers—Gannerkote will lead IDT and continue advancing its mission of accelerating the pace of genomics.

To enable pharmaceutical researchers to move quickly into their high‑throughput screening experiments, global genomics solutions provider Integrated DNA Technologies (IDT) today released rapid genes, a new offering in its synthetic biology portfolio. Available from 125 base pairs (bp) to 2000 bp, IDT’s rapid genes are ready-to-use, next generation sequencing (NGS)-verified clonal genes shipped in as little as five business days. Rapid genes are priced at $0.15 USD per bp and delivered in a plate format for automated workflows.

Integrated DNA Technologies (IDT), a global leader in CRISPR genome editing solutions, inked a licensing agreement with SeQure Dx, a company focused on off-target analysis for preclinical and clinical gene modification customers, bolstering IDT’s complete CRISPR portfolio comprised of world-class RUO to CGMP solutions from design to analysis. The licensing agreement enables IDT to support cell and gene therapy developers through all phases of their CRISPR-based therapeutic programs by providing comprehensive off-target analysis services, powered by SeQure Dx’s GUIDE-seq technology, alongside IDT’s award-winning rhAmpSeq™ CRISPR Analysis System.

Amidst growing concerns from U.S. federal, state and local agencies over Highly Pathogenic Avian Influenza (HPAI) A (H5N1) detections in dairy cows, Integrated DNA Technologies today launched the Avian Influenza Type A (H5) Primers and Probe Set to enable researchers to identify, target, and trace the presence of clade 2.3.4.4b of the H5N1 virus across bird, environmental, dairy cow, and poultry farm samples. The new offering is available for online ordering through IDT’s Tech Access Program, which enables access to the most advanced research tools in development to accelerate innovation. IDT’s Avian Influenza A (H5) Primers and Probe Set is manufactured in a certified, template-free environment and includes an internal control to help confirm false negatives. An Avian Influenza Positive Sample Control is also available for purchase.

Global genomics solutions provider Integrated DNA Technologies (IDT) today announced the expansion of its synthetic biology operations with the opening of a new 25,000 square-foot-site in Coralville, IA. The two-story building will be dedicated to the manufacturing of IDT synthetic biology products, doubles IDT’s synthetic biology footprint, and enables IDT to further enhance its gene synthesis portfolio with differentiated offerings.

With a mission to accelerate the pace of genomics, Integrated DNA Technologies (IDT), a leading provider of differentiated next generation sequencing (NGS) solutions, announces the availability of xGen NGS products designed exclusively for the Ultima Genomics UG 100™ platform. The suite of new xGen NGS tools comprised of adapters, primers, and universal blockers can support a wide range of applications, including DNA, RNA and methylation sequencing workflows, as well as IDT’s proven hybridization capture chemistry. The products are designed to minimize sequence errors from PCR or sequencing that might impact demultiplexing. Orders can be placed here.

With a mission to accelerate the pace of genomics, Integrated DNA Technologies (IDT) has launched Collab Network, a first-of-its-kind IDT program aimed at uniting researchers and industry partners under a single, impactful research network to foster learning, collaboration and future technology development. The Collab Network Program was officially unveiled at the 2023 Advances in Genome Biology and Technology General Meeting taking place Feb. 6 to Feb. 9 in Hollywood, Fla.

On the heels of Integrated DNA Technologies’ xGen™ NGS portfolio launch in December, MLL, the Munich Leukemia Laboratory, one of the leading research and diagnostic laboratories for leukemias and lymphomas, has joined the global genomics solutions provider’s Align Program.